Papers
1
Total Citations
16
H-Index
1
About
A pioneer in minimally invasive urologic oncology, R.M. Scarpa has made defining contributions to robotic-assisted surgery, particularly in nephron-sparing techniques. His work is centered on advancing surgical precision and patient outcomes through novel robotic platforms and refined operative settings. Scarpa’s major contribution is the clinical validation of the novel Hugo™ RAS system for robot-assisted partial nephrectomy (RAPN). In his landmark 2024 study—the first off-clamp series using this modular platform—he demonstrated the feasibility and safety of a three-arm setting, achieving excellent perioperative outcomes. This work, already cited 16 times, is reshaping the standard for nephron-sparing surgery by proving that enhanced modularity can reduce ischemia time and preserve renal function without compromising oncologic control. Scarpa’s research directly addresses the critical need for adaptable, patient-tailored robotic configurations. By systematically documenting the setup, challenges, and results of this pioneering approach, he has provided a reproducible roadmap for surgical teams worldwide. His achievements position him at the forefront of the next generation of robotic urology, where flexibility and precision converge to redefine what is possible in complex renal surgery.
Research Focus
Key Achievements
Top Papers
- 1